《大行報告》瑞信:內地降準可助內銀股優化負債結構及減利息支出
瑞信發表報告,指人行公佈將降準0.5個百分點,釋放共1萬億元人民幣的準備金,金融機構加權平均存款準備金率爲8.9%,但指釋放的一部分資金將被金融機構用於歸還到期的MLF,還有一部分資金被金融機構用於彌補7月中下旬稅期高峯帶來的流動性缺口,料今次降準操影響屬中性。
但該行指對內地今次降準對內銀股影響屬正面,以及有助銀行業優化貸款結構,及降低利率開支。該行指,在預期釋內地放的1萬億元人民幣用於取代中期借貸便利(MLF)下,有助降低130億元人民幣開支。
瑞信指,維持對內銀股正面看法,喜愛招商銀行(03968.HK)及平安銀行(000001.SZ),認爲是在內銀股在公佈上半年業績前屬收集良機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.